Hassan Maishera
On Monday, the Injective team announced via X that Canary Capital has filed Amendment No. 3 to its S-1 for a Staked $INJ ETF with the SEC.
The ETF will hold spot INJ and target staking at least 90% of its institutional holdings in the U.S.
Injective also provides a next-generation, highly interoperable smart contract platform based on Wasm 2.0, with advanced interchain capabilities. Injective utilizes a custom implementation of the Tendermint Proof-of-Stake consensus mechanism, providing instant transaction finality with lightning speed – sub-second block times (0.6s) while sustaining enormous throughput (25,000+ TPS). Injective is currently also leading new forms of innovation across a number of verticals, such as its pioneering work to integrate artificial intelligence with on-chain finance.
Injective has achieved a historic milestone of over 1 billion transactions to date, with one of the fastest chains built to date. The Injective ecosystem includes 100+ projects and over 500,000 community members globally. Injective was originally incubated by Binance and is also backed by a group of prominent investors, including Pantera Capital, Jump Crypto, and Mark Cuban.
Injective is an open, interoperable layer-one blockchain for building powerful DeFi applications. Injective uniquely provides plug-and-play financial infrastructure primitives, such as a high-performance on-chain decentralized exchange infrastructure, decentralized bridges, oracles, and a composable smart contract layer with CosmWasm. INJ is trading at $7.34, down 4.4% in the last 24 hours.
